Works matching IS 15391604 AND DT 2020 AND VI 19 AND IP 6

Results: 17

A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulations.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 975, doi. 10.1002/pst.2049

By:

Asano, Junichi;
Hirakawa, Akihiro

Publication type:

Article

Optimal decision‐making in oncology development programs based on probability of success for phase III utilizing phase II/III data on response and overall survival.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 861, doi. 10.1002/pst.2042

By:

Götte, Heiko;
Xiong, Junyuan;
Kirchner, Marietta;
Demirtas, Hakan;
Kieser, Meinhard

Publication type:

Article

Evaluating the time‐dependent predictive accuracy for event‐to‐time outcome with a cure fraction.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 955, doi. 10.1002/pst.2048

By:

Wang, Ziwen;
Wang, Xiaoguang

Publication type:

Article

Comparing Bayesian early stopping boundaries for phase II clinical trials.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 928, doi. 10.1002/pst.2046

By:

Jiang, Liyun;
Yan, Fangrong;
Thall, Peter F.;
Huang, Xuelin

Publication type:

Article

MMRM vs joint modeling of longitudinal responses and time to study drug discontinuation in clinical trials using a "de jure" estimand.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 909, doi. 10.1002/pst.2045

By:

García‐Hernandez, Alberto;
Pérez, Teresa;
Pardo, María del Carmen;
Rizopoulos, Dimitris

Publication type:

Article

Regional consistency and sample size considerations in a multiregional equivalence trial.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 897, doi. 10.1002/pst.2044

By:

Wu, Si‐Cheng;
Xu, Jin‐Fang;
Zhang, Xin‐Ji;
Li, Zhi‐Wei;
He, Jia

Publication type:

Article

Pharmacokinetic/pharmacodynamic data extrapolation models for improved pediatric efficacy and toxicity estimation, with application to secondary hyperparathyroidism.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 882, doi. 10.1002/pst.2043

By:

Basu, Cynthia;
Ma, Xiaoye;
Mo, May;
Xia, Hong Amy;
Brundage, Richard;
Al‐Kofahi, Mahmoud;
Carlin, Bradley P.

Publication type:

Article

Score and deviance residuals based on the full likelihood approach in survival analysis.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 940, doi. 10.1002/pst.2047

By:

Halabi, Susan;
Dutta, Sandipan;
Wu, Yuan;
Liu, Aiyi

Publication type:

Article

Imputation of missing covariate in randomized controlled trials with a continuous outcome: Scoping review and new results.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 840, doi. 10.1002/pst.2041

By:

Kayembe, Mutamba T.;
Jolani, Shahab;
Tan, Frans E. S.;
Breukelen, Gerard J. P.

Publication type:

Article

Assurance for clinical trial design with normally distributed outcomes: Eliciting uncertainty about variances.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 827, doi. 10.1002/pst.2040

By:

Alhussain, Ziyad A.;
Oakley, Jeremy E.

Publication type:

Article

A Bayesian approach in design and analysis of pediatric cancer clinical trials.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 814, doi. 10.1002/pst.2039

By:

Ye, Jingjing;
Reaman, Gregory;
De Claro, R. Angelo;
Sridhara, Rajeshwari

Publication type:

Article

Comparison of statistical methods for recurrent event analysis using pediatrics asthma data.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 803, doi. 10.1002/pst.2032

By:

Yadav, C. P.;
Lodha, Rakesh;
Kabra, S. K.;
Sreenivas, V.;
Sinha, Abhinav;
Khan, M. A.;
Pandey, R. M.

Publication type:

Article

Empirical profile Bayesian estimation for extrapolation of historical adult data to pediatric drug development.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 787, doi. 10.1002/pst.2031

By:

Wu, Yaoshi;
Hui, Jianan;
Deng, Qiqi

Publication type:

Article

Bayesian optimal phase II clinical trial design with time‐to‐event endpoint.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 776, doi. 10.1002/pst.2030

By:

Zhou, Heng;
Chen, Cong;
Sun, Linda;
Yuan, Ying

Publication type:

Article

Investigating the appropriateness of different concordance measures in a time‐to‐event setting.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 763, doi. 10.1002/pst.2029

By:

Caetano, Samantha‐Jo;
Pond, Gregory

Publication type:

Article

Comparison of two treatments in the presence of competing risks.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 746, doi. 10.1002/pst.2028

By:

Lyu, Jingjing;
Chen, Jinbao;
Hou, Yawen;
Chen, Zheng

Publication type:

Article

Issue Information.

Published in:: Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 743, doi. 10.1002/pst.1962
Publication type:: Article